We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
Royal London Asset Management
226
Royal London Asset Management
United Kingdom
$70.5M -$546K -17,359 -0.8%
TPSF
227
Texas Permanent School Fund
Texas
$70.2M -$764K -24,274 -1%
Pzena Investment Management
228
Pzena Investment Management
New York
$69.8M +$58.9K +1,871 +0.1%
Robeco Institutional Asset Management
229
Robeco Institutional Asset Management
Netherlands
$69.5M -$91.3M -2,901,857 -56%
Comerica Bank
230
Comerica Bank
Texas
$69.1M -$62.3K -1,980 -0.1%
DnB Asset Management
231
DnB Asset Management
Norway
$69M -$5.62M -178,716 -7%
KBC Group
232
KBC Group
Belgium
$68.1M +$7.73M +245,629 +12%
Commonwealth Equity Services
233
Commonwealth Equity Services
Massachusetts
$66.8M +$3.74M +118,869 +6%
HighTower Advisors
234
HighTower Advisors
Illinois
$66.2M +$1.02M +32,313 +2%
BFM
235
Boston Financial Management
Massachusetts
$66M -$584K -18,562 -0.9%
Victory Capital Management
236
Victory Capital Management
Texas
$65.5M -$21.7M -690,435 -24%
EDRH
237
Edmond de Rothschild Holding
Switzerland
$65.1M -$4.43M -140,885 -6%
LPL Financial
238
LPL Financial
California
$64.8M +$29.4M +935,455 +79%
Los Angeles Capital Management
239
Los Angeles Capital Management
California
$64.2M +$10M +319,272 +18%
AAM
240
Advisors Asset Management
Colorado
$63.6M -$6.9M -219,412 -10%
NIMC
241
NWQ Investment Management Company
California
$63.5M -$79.2M -2,518,806 -55%
OTPPB
242
Ontario Teachers' Pension Plan Board
Ontario, Canada
$62.6M -$287K -9,138 -0.4%
ECP
243
Empyrean Capital Partners
California
$62.5M -$9.57M -304,079 -13%
ASC
244
Atalanta Sosnoff Capital
New York
$62.5M +$6.93M +220,417 +12%
GF
245
Gabelli Funds
New York
$61.9M +$1.33M +42,160 +2%
QI
246
QS Investors
New York
$60.5M +$14.4M +458,826 +30%
MHC
247
Meyer Handelman Company
New York
$59.6M -$666K -21,164 -1%
FIM
248
Foresters Investment Management
New York
$59.4M
GIBU
249
Gulf International Bank (UK)
United Kingdom
$59.2M +$1.44M +45,691 +2%
CEP
250
Chicago Equity Partners
Illinois
$58.6M +$11.8M +376,468 +24%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.